Analyst Ranking
Top 35%
#1676 out of 4794 analysts
Average Return
+1.45%
Win Rate
44%21 out of 48
Risk vs Reward
Poor
Good

Mason Carrico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Caredx IncCDNA
+228.02%$7.21$23.65
2023-11-08 -
2024-11-08
Strong Buy
Caredx IncCDNA
+174.15%$8.28$22.70
2024-04-16 -
2025-01-21
Strong Buy
Natera IncNTRA
+153.73%$66.00$167.46
2024-01-29 -
2025-01-21
Strong Buy
Natera IncNTRA
+149.63%$67.50$168.50
2024-01-16 -
2025-01-16
Strong Buy
Guardant Health IncGH
+76.84%$25.52$45.13
2024-05-23 -
2025-01-21
Strong Buy

Mason Carrico Analyst Color

Get additional color on Mason Carrico's coverage of popular stocks

Mason Carrico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Myriad Genetics IncMYGN
4Hold$20.00+59.11%Reiterates
6 days ago
Vericel CorpVCEL
1Strong Buy$65.00+9.13%Reiterates
7 days ago
Castle Biosciences IncCSTL
7Strong Buy$41.00+53.44%Reiterates
20 days ago
Illumina IncILMN
6Strong Buy$184.00+30.21%Maintains
2 months ago
10x Genomics IncTXG
5Strong Buy$30.00+85.64%Reiterates
3 months ago
Natera IncNTRA
4Strong Buy$125.00-25.36%Reiterates
5 months ago
Hologic IncHOLX
2Strong Buy$92.00+30.74%Reiterates
6 months ago
Neogenomics IncNEO
1Strong Buy$19.00+33.99%Reiterates
6 months ago
Guardant Health IncGH
4Strong Buy$44.00-2.50%Reiterates
8 months ago
Caredx IncCDNA
8Strong Buy$18.00-20.70%Maintains
8 months ago
Dermtech IncDMTKQ
4Hold$1.50+1,495.74%Reiterates
9 months ago
Oncocyte CorpOCX
2Hold$4.00+88.68%Reiterates
9 months ago
Pacific Biosciences Of California IncPACB
1Strong Buy$11.00N/AInitiates Coverage On
a year ago
Cytek Biosciences IncCTKB
1Strong Buy$9.00N/AInitiates Coverage On
a year ago
Akoya Biosciences IncAKYA
4Strong Buy$9.00N/AMaintains
a year ago
Veracyte IncVCYT
3Strong Buy$34.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.